U.S., Nov. 19 -- An application to own the trademark for 'YOJEMTU' has been filed on Mar. 04, 2025.
Owner(s):
Synox Therapeutics UK Limited; John Eccles House,, , UNITED KINGDOM
Goods and/or Services:
For: Pharmaceutical and biological preparations for the treatment of cancer and non-cancer fibrotic and inflammatory diseases for medical purposes; monoclonal antibodies for medical use; pharmaceutical preparations for the prevention, diagnosis and treatment of cancer and immune-mediated inflammatory and autoimmune diseases, namely tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft-tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer,...